Yoon, Y., Park, H. Y., Chae, M. K., Jang, S. Y., & Yoon, J. S. Therapeutic effect of selective interleukin-2-inducible tyrosine kinase inhibitor in orbital fibroblasts from patients with Graves’ orbitopathy. The Japan Endocrine Society.
Chicago Style (17th ed.) CitationYoon, Yeonjung, Hyun Young Park, Min Kyung Chae, Sun Young Jang, and Jin Sook Yoon. Therapeutic Effect of Selective Interleukin-2-inducible Tyrosine Kinase Inhibitor in Orbital Fibroblasts from Patients with Graves’ Orbitopathy. The Japan Endocrine Society.
MLA (9th ed.) CitationYoon, Yeonjung, et al. Therapeutic Effect of Selective Interleukin-2-inducible Tyrosine Kinase Inhibitor in Orbital Fibroblasts from Patients with Graves’ Orbitopathy. The Japan Endocrine Society.
Warning: These citations may not always be 100% accurate.